Cargando…
PDLIM2 Suppression Inhibit Proliferation and Metastasis in Kidney Cancer
SIMPLE SUMMARY: Kidney cancer is a common malignant tumor in both men and women and accounts for approximately 5% of all cancer incidences. Advances in imaging technology and the increasing use of health care facilities have led to the early detection of kidney cancer cases. However, many individual...
Autores principales: | Yuk, Hyeong-Dong, Lee, Kyoung-Hwa, Lee, Hye-Sun, Jeong, Seung-Hwan, Kho, Yongseok, Jeong, Chang-Wook, Kim, Hyeon-Hoe, Ku, Ja-Hyeon, Kwak, Cheol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232651/ https://www.ncbi.nlm.nih.gov/pubmed/34203785 http://dx.doi.org/10.3390/cancers13122991 |
Ejemplares similares
-
Prognostic Impact of Preoperative Renal Insufficiency on Metastasis-Free Survival after Radical Cystectomy
por: Suh, Jungyo, et al.
Publicado: (2021) -
Clinical determinants of recurrence in pTa bladder cancer following transurethral resection of bladder tumor
por: Jeong, Seung-hwan, et al.
Publicado: (2022) -
High Carbohydrate Antigen 19-9 Levels Indicate Poor Prognosis of Upper Tract Urothelial Carcinoma
por: Jeong, Seung-hwan, et al.
Publicado: (2022) -
Should intravesical Bacillus Calmette–Guerin (BCG) treatment be administered to patients with T0 after repeat transurethral resection of bladder tumor in patients with high-risk non-muscle invasive bladder cancer?
por: Yuk, Hyeong Dong, et al.
Publicado: (2018) -
Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Non-muscle Invasive Bladder Cancer Patients: Initial Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor Setting
por: Yuk, Hyeong Dong, et al.
Publicado: (2019)